Key points are not available for this paper at this time.
Supplementary Figure S7. BCMA CAR-T Therapy Attenuates BAFF/GALECTIN/MK Pathway-mediated Immunosuppression and Activates MIF Pathway-mediated Anti-MM Immunity.
Yang et al. (Fri,) studied this question.